Title : Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.

Pub. Date : 2012 Mar

PMID : 22357577






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 METHODS AND RESULTS: A post-hoc analysis was carried out of the placebo group of the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan) trial, which enrolled patients hospitalized for HF with an ejection fraction (EF) <=40% and no history of primary significant liver disease or acute hepatic failure. Tolvaptan arginine vasopressin Homo sapiens